Solve Inc - subsequently doing business as SolveBio - had been a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations effectively to connect and use external and internal genomic information. Acquired in early January 2023, by Quartz Bio, a Swiss-based company providing clinical bioinformatics services to the health sector. SolveBio is now part of that firm's suite of software-as-a-service (SaaS) solutions which has integrated with acquired firm's ntelligent technologies and enterprise data management platform, providing a single, scalable solution supporting clinical sample inventory management and biomarker data management for the biotech and pharma sectors. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises and has developed technology to leverage molecular information for therapeutic development at leading biopharma organizations. Customers are able to answer critical questions in real time and run analytics on molecular information from internal, external, collaborator, and clinical trial data feeds and connect it to real-world evidence in order to accelerate development through more accurate risk assessment, target validation, and population stratification. SolveBio deploys intelligent technologies and on-demand expertise to drive precision medicine. The firm partners with diagnostic labs and biopharma to leverage the Genomic Intelligence Platform -- extracting complex biomedical data. By connecting specialists to real-time data, SolveBio develops actionable information assets for life science enterprises.
